NOTARFRANCHI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 233
EU - Europa 188
AS - Asia 84
AF - Africa 7
OC - Oceania 1
Totale 513
Nazione #
US - Stati Uniti d'America 228
IT - Italia 48
SG - Singapore 45
IE - Irlanda 40
SE - Svezia 38
CN - Cina 34
DE - Germania 17
FR - Francia 15
AT - Austria 5
CA - Canada 5
CI - Costa d'Avorio 5
CZ - Repubblica Ceca 5
FI - Finlandia 5
RU - Federazione Russa 5
GB - Regno Unito 3
IN - India 2
LT - Lituania 2
TR - Turchia 2
AU - Australia 1
BG - Bulgaria 1
IR - Iran 1
LU - Lussemburgo 1
NG - Nigeria 1
NL - Olanda 1
RO - Romania 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 513
Città #
Chandler 63
Dublin 40
Singapore 36
Boardman 21
Ashburn 19
Shanghai 19
Parma 14
Marseille 12
Munich 10
New York 8
Ann Arbor 6
Beijing 6
Bremen 6
Princeton 6
Rome 6
Abidjan 5
Fairfield 5
Vienna 5
Brno 4
Helsinki 4
Los Angeles 4
San Mateo 4
Santa Clara 4
Bologna 3
Cesena 3
Des Moines 3
Reggio Emilia 3
Toronto 3
Fremont 2
Kocaeli 2
Medesano 2
Norwalk 2
Ottawa 2
Palermo 2
Piacenza 2
Pune 2
Seattle 2
Shenyang 2
West Jordan 2
Wilmington 2
Augusta 1
Bratislava 1
Castel San Giovanni 1
Catania 1
Charlotte 1
Dallas 1
Denver 1
Focsani 1
Gatchina 1
Hangzhou 1
Lagos 1
Leawood 1
London 1
Lurate Caccivio 1
Milan 1
Montesilvano 1
Moscow 1
Naples 1
Nerviano 1
Phoenix 1
Sabz 1
Sofia 1
Sydney 1
Tampa 1
Turku 1
Volgograd 1
Waltham 1
Washington 1
Totale 374
Nome #
Application of next-generation sequencing for the genomic characterization of patients with smoldering myeloma 89
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients 74
Concomitant primary hyperparathyroidism in patients with multiple myeloma: A possible link? 61
Combining bortezomib to high dose melphalan as conditioning regimen results in the improvement of the response rate in newly diagnosed young multiple myeloma patients 60
Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results 59
Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma 58
The impact of CD56 expression in smoldering myeloma patients on early progression 44
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response 29
CD38 expression by plasma cells in extramedullary multiple myeloma 24
Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma 23
IMPACT OF TREATMENT WITH IDELALISIB PLUS RITUXIMAB ON CLINICAL AND CYTOGENETICS PROFILE IN RELAPSE/REFRACTORY CLL: THE EXPERIENCE OF THE UNIVERSITY HOSPITAL OF PARMA 14
Totale 535
Categoria #
all - tutte 2.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.813


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 0 0 0 2 1 0 0
2020/202148 13 0 1 1 4 0 1 5 2 10 5 6
2021/202251 0 4 3 2 0 0 11 5 1 2 0 23
2022/2023203 22 24 18 19 10 22 9 12 49 5 7 6
2023/2024119 4 7 1 4 9 25 14 2 5 8 13 27
2024/2025111 12 11 21 44 23 0 0 0 0 0 0 0
Totale 535